Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.35 |
| ▸ | HTR2A | P28223 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | MPI | P34949 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | BRD4 | O60885 | 1/20 | 0.33 |
| ▸ | NOTUM | Q6P988 | 2/20 | 0.33 |
| ▸ | DRD2 | P14416 | 1/20 | 0.32 |
| ▸ | DRD4 | P21917 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9526800 | 0.73 | NPSR1 (0.38) | NPSR1ALDH1A1HTR2ABRD4DRD2 | |
| SCHEMBL14968650 | 0.72 | NOTUM (0.36) | NPSR1ALDH1A1HTR2ANOTUM | |
| SCHEMBL874232 | 0.72 | HTR2A (0.35) | NPSR1HTR2AGAA | |
| SCHEMBL1478505 | 0.70 | HTR2A (0.46) | NPSR1HTR2A | |
| SCHEMBL558875 | 0.69 | HTR2A (0.39) | HTR2A | |
| SCHEMBL855127 | 0.66 | MME (0.42) | NPSR1ALDH1A1LMNAGAAMAPT | |
| SCHEMBL3370706 | 0.65 | HTR2A (0.44) | HTR2A | |
| SCHEMBL19647403 | 0.65 | NPSR1 (0.35) | NPSR1HTR2ABRD4DRD2DRD4 | |
| SCHEMBL7759938 | 0.65 | ALDH1A1 (0.38) | ALDH1A1HTR2AMAPTHTTNOTUM | |
| SCHEMBL2354334 | 0.65 | HTR2A (0.42) | HTR2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260033524-A1 | FLAVOR MODIFYING COMPOSITIONS | CORN PRODUCTS DEV INC (US) | 2026-02-05 | — | — | US | disclosed |
| EP-4561366-A1 | FLAVOR MODIFYING COMPOSITION | CORN Products Development Inc. (US) | 2025-06-04 | — | — | EP | disclosed |
| CN-119894387-A | Flavor modulating composition | 玉米产品开发公司 | 2025-04-25 | — | — | CN | disclosed |
| US-20250081996-A1 | FLAVOR MODIFYING COMPOSITION | PURECIRCLE SDN BHD (MY) | 2025-03-13 | — | — | US | disclosed |
| EP-4380375-A1 | METHODS FOR THERMALLY INHIBITING STARCH | CORN Products Development Inc. (US) | 2024-06-12 | — | — | EP | disclosed |
| CN-117835831-A | Flavor modulating composition | 玉米产品开发公司 | 2024-04-05 | — | — | CN | disclosed |
| WO-2024026450-A1 | FLAVOR MODIFYING COMPOSITION | CORN PRODUCTS DEVELOPMENT, INC. (US) | 2024-02-01 | — | — | WO | disclosed |
| WO-2023014926-A1 | FLAVOR MODIFYING COMPOSITION | CORN PRODUCTS DEVELOPMENT, INC. (US) | 2023-02-09 | — | — | WO | disclosed |
| EP-3554275-A1 | MODIFYING OR ENHANCING A FLAVOR OF FOOD AND BEVERAGE PRODUCTS | Tate & Lyle Ingredients Americas LLC (US) | 2019-10-23 | — | — | EP | disclosed |
| US-20190313680-A1 | MODIFYING OR ENHANCING A FLAVOR OF FOOD AND BEVERAGE PRODUCTS | TATE & LYLE INGREDIENTS AMERICAS LLC (US) | 2019-10-17 | — | — | US | disclosed |
| WO-2018109464-A1 | MODIFYING OR ENHANCING A FLAVOR OF FOOD AND BEVERAGE PRODUCTS | TATE & LYLE INGREDIENTS AMERICAS LLC (US) | 2018-06-21 | — | — | WO | disclosed |
| WO-2006101409-A1 | USE OF VEGETABLE OIL TO STABILISE ESSENTIAL OILS AND PROMOTE ABSORPTION ACROSS SKIN | PRO-PERSPIRANT LIMITED (NZ) | 2006-09-28 | — | — | WO | disclosed |
| US-5952357-A | Treating diseases of the anterior horn cells | CORNELL RESEARCH FOUNDATION, INC. (US) | 1999-09-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260033524-A1 | FLAVOR MODIFYING COMPOSITIONS | TAS2R42, TAS2R7, TAS2R31 | NPSR1 3503/4885ALDH1A1 970/4885HTR2A 1824/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.